research use only

Cyclobenzaprine HCl 5-HT Receptor antagonist

Cat.No.S4283

Cyclobenzaprine HCl(Cyclobenzaprine hydrochloride) is a muscle relaxant by blocking pain sensations, used for the treatment of muscle spasms; A 5-HT2 receptor antagonist.
Cyclobenzaprine HCl 5-HT Receptor antagonist Chemical Structure

Chemical Structure

Molecular Weight: 311.85

Jump to

Quality Control

Batch: Purity: 99.97%
99.97

Solubility

In vitro
Batch:

DMSO : 62 mg/mL (198.81 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 62 mg/mL

Ethanol : 62 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 311.85 Formula

C20H22ClN

Storage (From the date of receipt)
CAS No. 6202-23-9 Download SDF Storage of Stock Solutions

Synonyms Cyclobenzaprine hydrochloride Smiles CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl

Mechanism of Action

Targets/IC50/Ki
5-HT2 receptor
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03700970 Completed
Breast Reconstruction|Anesthesia|Transverse Abdominis Plane Block
Vanderbilt University Medical Center
June 13 2019 Phase 4
NCT03443960 Completed
Healthy Subjects
Tonix Pharmaceuticals Inc.
January 29 2018 Phase 1
NCT03168022 Completed
Healthy Adults
Tonix Pharmaceuticals Inc.
December 16 2015 Phase 1
NCT01921296 Terminated
Sleep Initiation and Maintenance Disorders|Pain
Lynn Henry|Damon Runyon Cancer Research Foundation|University of Michigan Rogel Cancer Center
August 2013 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map